Literature DB >> 2897399

Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis.

A Gessain1, C Caudie, O Gout, J C Vernant, L Maurs, C Giordano, G Malone, E Tournier-Lasserve, M Essex, G de-Thé.   

Abstract

Tropical spastic paraparesis (TSP), a neuromyelopathy predominantly involving the pyramidal tract and commonly observed in tropical and equatorial areas, was recently found to be associated with human T lymphotropic virus type I (HTLV-I). We investigated sera and cerebrospinal fluid (CSF) from 19 patients with TSP who were from the Caribbean area, French Guiana, and Africa. Our results showed an elevated intra-blood-brain barrier IgG synthesis rate and an elevated IgG index, with an increased HTLV-I antibody-to-albumin ratio and the presence of CSF oligoclonal bands in the majority of the patients. These data, in association with similar HTLV-I antibody patterns between patients with TSP who were from these three regions, strengthen the probable etiologic role of HTLV-I in the pathogenesis of such chronic neuromyelopathies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897399     DOI: 10.1093/infdis/157.6.1226

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

Review 2.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Effect of human T lymphotropic retrovirus-I exposure on cultured human glioma cell lines.

Authors:  B Macchi; B Caronti; M Pezzella; E Bonmassar; G Lauro
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.

Authors:  P S Sarin; P Rodgers-Johnson; D K Sun; A H Thornton; O S Morgan; W N Gibbs; C Mora; G McKhann; D C Gajdusek; C J Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.

Authors:  B Kitze; K Usuku; S Izumo; M Nakamura; H Shiraki; S Ijichi; S Yashiki; T Fujiyoshi; S Sonoda; M Osame
Journal:  J Neurol       Date:  1996-05       Impact factor: 4.849

Review 6.  Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.

Authors:  P S Dixon; A J Bodner; M Okihiro; A Milbourne; A Diwan; J M Nakamura
Journal:  West J Med       Date:  1990-03

7.  Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.

Authors:  A Ono; M Mochizuki; K Yamaguchi; N Miyata; T Watanabe
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

8.  Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

Authors:  P M Hoffman; S Dhib-Jalbut; J A Mikovits; D S Robbins; A L Wolf; G K Bergey; N C Lohrey; O S Weislow; F W Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.

Authors:  K Kayembe; P Goubau; J Desmyter; R Vlietinck; H Carton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

10.  Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  A Gessain; A Louie; O Gout; R C Gallo; G Franchini
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.